000 | 01941 a2200541 4500 | ||
---|---|---|---|
005 | 20250513090727.0 | ||
264 | 0 | _c19960702 | |
008 | 199607s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMelotti, P | |
245 | 0 | 0 |
_aInduction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. _h[electronic resource] |
260 |
_bBlood _cMar 1996 |
||
300 |
_a2221-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD34 _xbiosynthesis |
650 | 0 | 4 |
_aAntigens, Differentiation _xbiosynthesis |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Lineage |
650 | 0 | 4 | _aClone Cells |
650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
650 | 0 | 4 | _aErythroid-Specific DNA-Binding Factors |
650 | 0 | 4 | _aGATA1 Transcription Factor |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGrowth Substances _xpharmacology |
650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xbiosynthesis |
650 | 0 | 4 | _aProto-Oncogene Proteins c-myb |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
650 | 0 | 4 |
_aStem Cells _xclassification |
650 | 0 | 4 |
_aTrans-Activators _xbiosynthesis |
650 | 0 | 4 |
_aTranscription Factors _xbiosynthesis |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aCalabretta, B | |
773 | 0 |
_tBlood _gvol. 87 _gno. 6 _gp. 2221-34 |
|
999 |
_c8629421 _d8629421 |